Sutro Biopharma, Inc.
STRONASDAQHealthcare● Active
$25.95
+$0.54(+2.13%)
Market Cap$251124793
P/E Ratio—
52W High$43.85
52W Low$6.7
Sutro Biopharma, Inc.（STRO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · STRO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.19B) | ($0.23B) | ($0.11B) | ($0.12B) | ($0.11B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.01B | $0.02B | $0.02B | $0.03B | $0.02B |
| Change in Working Capital | ($0.05B) | $0.01B | ($0.03B) | $0.10B | ($0.02B) |
| Net Cash from Operations | ($0.18B) | ($0.19B) | ($0.11B) | $0.00B | ($0.08B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.02B) |
| Purchases of Investments | ($0.26B) | ($0.46B) | ($0.46B) | ($0.22B) | ($0.25B) |
| Sales of Investments | $0.31B | $0.68B | $0.46B | $0.19B | $0.17B |
| Net Cash from Investing | $0.05B | $0.22B | ($0.00B) | ($0.04B) | ($0.10B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.00B) | ($0.01B) | ($0.01B) | $0.00B |
| Net Cash from Financing | $0.00B | $0.09B | $0.14B | $0.05B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.18B) | ($0.19B) | ($0.12B) | ($0.00B) | ($0.10B) |
| FCF Margin %(computed) | -174.59% | -313.71% | -75.41% | -6.36% | -156.76% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Sutro Biopharma, Inc.
关于Sutro Biopharma, Inc.（STRO）现金流量表
Sutro Biopharma, Inc. 2025财年经营活动现金流($0.18B)，自由现金流($0.18B)（FCF利润率-174.59%），资本支出($0.00B)。
常见问题
STRO · 4 问Sutro Biopharma, Inc. 2025财年自由现金流($0.18B)，同比up8.1%。
STRO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10